ATE214269T1 - Oral anzuwendende flüssige arzneilösung - Google Patents
Oral anzuwendende flüssige arzneilösungInfo
- Publication number
- ATE214269T1 ATE214269T1 AT98202077T AT98202077T ATE214269T1 AT E214269 T1 ATE214269 T1 AT E214269T1 AT 98202077 T AT98202077 T AT 98202077T AT 98202077 T AT98202077 T AT 98202077T AT E214269 T1 ATE214269 T1 AT E214269T1
- Authority
- AT
- Austria
- Prior art keywords
- medicinal solution
- oral application
- liquid medicinal
- weight
- volume
- Prior art date
Links
- 239000007788 liquid Substances 0.000 title 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 abstract 2
- 239000000654 additive Substances 0.000 abstract 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- 230000000996 additive effect Effects 0.000 abstract 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008297 liquid dosage form Substances 0.000 abstract 1
- 229940100688 oral solution Drugs 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
- 229960003454 tamoxifen citrate Drugs 0.000 abstract 1
- FQZYTYWMLGAPFJ-OQKDUQJOSA-N tamoxifen citrate Chemical compound [H+].[H+].[H+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 FQZYTYWMLGAPFJ-OQKDUQJOSA-N 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97201964 | 1997-06-27 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE214269T1 true ATE214269T1 (de) | 2002-03-15 |
Family
ID=8228492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT98202077T ATE214269T1 (de) | 1997-06-27 | 1998-06-23 | Oral anzuwendende flüssige arzneilösung |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US6127425A (de) |
| EP (1) | EP0893121B1 (de) |
| JP (1) | JPH1171269A (de) |
| AT (1) | ATE214269T1 (de) |
| DE (1) | DE69804169T2 (de) |
| DK (1) | DK0893121T3 (de) |
| ES (1) | ES2174388T3 (de) |
| PT (1) | PT893121E (de) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6136799A (en) * | 1998-04-08 | 2000-10-24 | Abbott Laboratories | Cosolvent formulations |
| FI982733L (fi) | 1998-12-17 | 2000-06-18 | Orion Yhtymae Oyj | Trifenyylietyleeniantiestrogeenien liukoisia koostumuksia |
| FI109332B (fi) | 1998-12-17 | 2002-07-15 | Orion Yhtymae Oyj | Toremifeenin liukoisia koostumuksia |
| US6541367B1 (en) * | 2000-01-18 | 2003-04-01 | Applied Materials, Inc. | Very low dielectric constant plasma-enhanced CVD films |
| FR2910317B1 (fr) * | 2006-12-21 | 2009-02-13 | Philippe Perovitch | Forme galenique pour l'administration par voie transmuqueuse de paracetamol |
| KR101025498B1 (ko) * | 2008-05-02 | 2011-03-31 | (주)이엘티사이언스 | 염산브롬헥신 경구용 액제 복합조성물 및 그 제조방법 |
| WO2012142029A2 (en) | 2011-04-10 | 2012-10-18 | Florida A&M University | Serms for the treatment of estrogen receptor-mediated disorders |
| ITUA20162292A1 (it) * | 2016-04-05 | 2017-10-05 | Gb Pharma S R L | Uso del tamoxifene per il trattamento della fibrosi cistica in pazienti di entrambi i sessi |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE293263C (de) * | ||||
| EP0120907A1 (de) * | 1982-10-13 | 1984-10-10 | Aston Molecules Limited | Pharmazeutische präparate zur anwendung in der therapie von tumoren |
| GB8604528D0 (en) * | 1986-02-24 | 1986-04-03 | Ici Plc | Therapeutic agents |
| DD293263A5 (de) * | 1990-03-23 | 1991-08-29 | Adw,Zi Fuer Molekularbiologie,De | Mittel zur hemmung des tumorwachstums |
| GB9126209D0 (en) * | 1991-12-10 | 1992-02-12 | Orion Yhtymae Oy | Drug formulations for parenteral use |
| IT1263831B (it) * | 1993-01-29 | 1996-09-04 | Paolo Chiesi | Complessi di inclusione multicomponente ad elevata solubilita' costituiti da un farmaco di tipo basico, un acido ed una ciclodestrina |
| DE4335876A1 (de) * | 1993-10-17 | 1995-04-20 | Schering Ag | Kombination von Progesteronantagonisten und Antiöstrogenen mit partialer agonistischer Wirkung für die Hormonsubstitutions-Therapie für peri- und postmenopausale Frauen |
| US5683993A (en) * | 1995-06-22 | 1997-11-04 | Ciba Vision Corporation | Compositions and methods for stabilizing polymers |
| TW389694B (en) * | 1995-08-17 | 2000-05-11 | Novartis Ag | Compositions including o-carboxyalkyl chitosan and methods of use in ophthalmics |
-
1998
- 1998-06-23 EP EP98202077A patent/EP0893121B1/de not_active Expired - Lifetime
- 1998-06-23 PT PT98202077T patent/PT893121E/pt unknown
- 1998-06-23 AT AT98202077T patent/ATE214269T1/de active
- 1998-06-23 DK DK98202077T patent/DK0893121T3/da active
- 1998-06-23 DE DE69804169T patent/DE69804169T2/de not_active Expired - Lifetime
- 1998-06-23 ES ES98202077T patent/ES2174388T3/es not_active Expired - Lifetime
- 1998-06-24 JP JP10176890A patent/JPH1171269A/ja not_active Withdrawn
- 1998-06-26 US US09/106,172 patent/US6127425A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0893121A1 (de) | 1999-01-27 |
| US6127425A (en) | 2000-10-03 |
| EP0893121B1 (de) | 2002-03-13 |
| PT893121E (pt) | 2002-06-28 |
| DE69804169T2 (de) | 2002-08-29 |
| ES2174388T3 (es) | 2002-11-01 |
| JPH1171269A (ja) | 1999-03-16 |
| DK0893121T3 (da) | 2002-06-17 |
| DE69804169D1 (de) | 2002-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE327977T1 (de) | Tetrahydrochinolin-derivate als crth2 antagonisten | |
| FI872864A0 (fi) | Menetelmä farmaseuttisesti aktiivisten bentsimidatsolijohdannaisten valmistamiseksi | |
| NO870241D0 (no) | Hypoglykemiske tiazolidindioner. | |
| SE8700498L (sv) | Nya farmakologiskt aktiva foreningar | |
| EA200000920A1 (ru) | Производные бициклических гидроксамовых кислот | |
| DE3681400D1 (de) | Mittel zur mundhygiene. | |
| EA200200431A1 (ru) | Фармацевтические композиции, обеспечивающие повышенные концентрации лекарства | |
| DE3770786D1 (de) | Mittel zur erhoehung der transdermalen permeation. | |
| KR890016966A (ko) | 신규 항바이러스제 | |
| HUT67661A (en) | New pyrazine derivatives, their preparation and pharmaceutical compositions containing them | |
| FR2712807B1 (fr) | Composition solide mucoadhésive, thérapeutique ou hygiénique, pour administration par application sur la muqueuse buccale ou nasale . | |
| ATE214269T1 (de) | Oral anzuwendende flüssige arzneilösung | |
| JPS54160753A (en) | Nail enamel | |
| ATE80313T1 (de) | Mittel zur erhoehung des transdermalen penetrationsflusses. | |
| KR880007060A (ko) | 제약 조성물 | |
| SE8600658D0 (sv) | Novel composition of matter | |
| DE69531736D1 (de) | Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe | |
| FI953566A0 (fi) | Tahdospironia tai sen analogeja sisältäviä koostumuksia | |
| FI803202L (fi) | Fosfonohydroxiaettiksyra foerfarande foer dess framstaellning och dess anvaendning saosom laekemedel | |
| JPS5781409A (en) | External plaster | |
| EA200100581A1 (ru) | Комбинация анальгетических лекарственных средств | |
| JPS57200361A (en) | "indomethacin(r)" pharmaceutical with low irritant action | |
| KR900701262A (ko) | 췌장염 등에 대한 치료제 | |
| IT1187743B (it) | Composizioni farmaceutiche a base di destrorfano per applicazione instranasale | |
| KR900017581A (ko) | α-아미노보론산 유도체를 함유하는 펩티드-약제 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EEIH | Change in the person of patent owner | ||
| EEIH | Change in the person of patent owner |